{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:30:30Z","timestamp":1772166630369,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40872"],"award-info":[{"award-number":["2023JJ40872"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30755"],"award-info":[{"award-number":["2023JJ30755"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02422-9","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T21:45:40Z","timestamp":1741902340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparative study of clinical outcomes and risk factors of tuberculosis in kidney transplant recipients from deceased donors"],"prefix":"10.1186","volume":"30","author":[{"given":"Hedong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingda","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanbiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longkai","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xubiao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongbin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"issue":"1","key":"2422_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14141","volume":"26","author":"PD Makanda-Charambira","year":"2022","unstructured":"Makanda-Charambira PD, et al. TB in paediatric kidney transplant recipients\u2014a single-centre experience. Pediatr Transpl. 2022;26(1): e14141.","journal-title":"Pediatr Transpl"},{"issue":"13","key":"2422_CR2","doi-asserted-by":"publisher","first-page":"6778","DOI":"10.3390\/ijerph18136778","volume":"18","author":"KA Alene","year":"2021","unstructured":"Alene KA, et al. Spatiotemporal patterns of tuberculosis in Hunan province, China. Int J Environ Res Public Health. 2021;18(13):6778.","journal-title":"Int J Environ Res Public Health"},{"key":"2422_CR3","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2147\/IDR.S249698","volume":"13","author":"C Ding","year":"2020","unstructured":"Ding C, et al. Epidemic trends of tuberculosis in China from 1990 to 2017: Evidence from the Global Burden of Disease Study. Infect Drug Resist. 2020;13:1663\u201372.","journal-title":"Infect Drug Resist"},{"issue":"11","key":"2422_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.15585\/mmwr.mm6911a2","volume":"69","author":"A MacNeil","year":"2020","unstructured":"MacNeil A, et al. Global epidemiology of tuberculosis and progress toward meeting global targets\u2014worldwide, 2018. MMWR Morb Mortal Wkly Rep. 2020;69(11):281\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2422_CR5","volume":"5","author":"JW Ai","year":"2016","unstructured":"Ai JW, et al. Updates on the risk factors for latent tuberculosis reactivation and their managements. Emerg Microb Infect. 2016;5(2): e10.","journal-title":"Emerg Microb Infect"},{"issue":"5","key":"2422_CR6","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1086\/514993","volume":"27","author":"N Singh","year":"1998","unstructured":"Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis. 1998;27(5):1266\u201377.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2422_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12750","volume":"19","author":"SD Costa","year":"2017","unstructured":"Costa SD, et al. Tuberculosis after kidney transplantation is associated with significantly impaired allograft function. Transpl Infect Dis. 2017;19(5): e12750.","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"2422_CR8","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/ajt.15220","volume":"19","author":"LA Viana","year":"2019","unstructured":"Viana LA, et al. Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: a retrospective cohort analysis. Am J Transplant. 2019;19(5):1421\u201331.","journal-title":"Am J Transplant"},{"issue":"5","key":"2422_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12943","volume":"20","author":"J Gras","year":"2018","unstructured":"Gras J, et al. Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: a multicentric case-control study in a low-endemic area. Transpl Infect Dis. 2018;20(5): e12943.","journal-title":"Transpl Infect Dis"},{"key":"2422_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/347103","volume":"2013","author":"K Boubaker","year":"2013","unstructured":"Boubaker K, et al. Mycobacterium tuberculosis infection following kidney transplantation. Biomed Res Int. 2013;2013: 347103.","journal-title":"Biomed Res Int"},{"issue":"2","key":"2422_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/tid.12501","volume":"18","author":"G Meinerz","year":"2016","unstructured":"Meinerz G, et al. Epidemiology of tuberculosis after kidney transplantation in a developing country. Transpl Infect Dis. 2016;18(2):176\u201382.","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"2422_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cmi.2015.03.010","volume":"21","author":"N Benito","year":"2015","unstructured":"Benito N, et al. Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study. Clin Microbiol Infect. 2015;21(7):651\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"2422_CR13","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","volume":"11","author":"M Tonelli","year":"2011","unstructured":"Tonelli M, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093\u2013109.","journal-title":"Am J Transplant"},{"issue":"4","key":"2422_CR14","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1183\/09031936.00000712","volume":"40","author":"D Bumbacea","year":"2012","unstructured":"Bumbacea D, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J. 2012;40(4):990\u20131013.","journal-title":"Eur Respir J"},{"issue":"2","key":"2422_CR15","doi-asserted-by":"publisher","first-page":"E169","DOI":"10.1111\/ctr.12077","volume":"27","author":"ID Marques","year":"2013","unstructured":"Marques ID, et al. Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil: a report of the last decade. Clin Transplant. 2013;27(2):E169\u201376.","journal-title":"Clin Transplant"},{"issue":"9","key":"2422_CR16","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1097\/TP.0000000000001224","volume":"100","author":"L Munoz","year":"2016","unstructured":"Munoz L, Santin M. Prevention and management of tuberculosis in transplant recipients: from guidelines to clinical practice. Transplantation. 2016;100(9):1840\u201352.","journal-title":"Transplantation"},{"issue":"4","key":"2422_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.5935\/0101-2800.20140073","volume":"36","author":"LM Higuita","year":"2014","unstructured":"Higuita LM, et al. Tuberculosis in renal transplant patients: the experience of a single center in Medellin-Colombia, 2005\u20132013. J Bras Nefrol. 2014;36(4):512\u20138.","journal-title":"J Bras Nefrol"},{"issue":"9","key":"2422_CR18","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1016\/j.transproceed.2012.09.060","volume":"44","author":"M Bodro","year":"2012","unstructured":"Bodro M, et al. Clinical features and outcomes of tuberculosis in solid organ transplant recipients. Transpl Proc. 2012;44(9):2686\u20139.","journal-title":"Transpl Proc"},{"issue":"9","key":"2422_CR19","doi-asserted-by":"publisher","first-page":"13513","DOI":"10.1111\/ctr.13513","volume":"33","author":"AK Subramanian","year":"2019","unstructured":"Subramanian AK, Theodoropoulos NM. Infectious diseases community of practice of the American society of, Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American society of transplantation. Clin Transplant. 2019;33(9):13513.","journal-title":"Clin Transplant"},{"issue":"3","key":"2422_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13566","volume":"23","author":"S Thitisuriyarax","year":"2021","unstructured":"Thitisuriyarax S, et al. Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country. Transpl Infect Dis. 2021;23(3): e13566.","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"2422_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050152","volume":"5","author":"CY Jeon","year":"2008","unstructured":"Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7): e152.","journal-title":"PLoS Med"},{"issue":"3","key":"2422_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/eji.201344301","volume":"44","author":"N Martinez","year":"2014","unstructured":"Martinez N, Kornfeld H. Diabetes and immunity to tuberculosis. Eur J Immunol. 2014;44(3):617\u201326.","journal-title":"Eur J Immunol"},{"issue":"10","key":"2422_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046824","volume":"7","author":"BK Podell","year":"2012","unstructured":"Podell BK, et al. Non-diabetic hyperglycemia exacerbates disease severity in Mycobacterium tuberculosis infected guinea pigs. PLoS ONE. 2012;7(10): e46824.","journal-title":"PLoS ONE"},{"issue":"5","key":"2422_CR24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1183\/09031936.00040007","volume":"30","author":"Y Kobashi","year":"2007","unstructured":"Kobashi Y, et al. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J. 2007;30(5):945\u201350.","journal-title":"Eur Respir J"},{"issue":"5","key":"2422_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3109\/00365548.2014.885657","volume":"46","author":"D Faurholt-Jepsen","year":"2014","unstructured":"Faurholt-Jepsen D, et al. Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls. Scand J Infect Dis. 2014;46(5):384\u201391.","journal-title":"Scand J Infect Dis"},{"key":"2422_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1471-2334-12-165","volume":"12","author":"D Faurholt-Jepsen","year":"2012","unstructured":"Faurholt-Jepsen D, et al. The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza. Tanzania BMC Infect Dis. 2012;12:165.","journal-title":"Tanzania BMC Infect Dis"},{"issue":"7","key":"2422_CR27","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/tmi.12120","volume":"18","author":"D Faurholt-Jepsen","year":"2013","unstructured":"Faurholt-Jepsen D, et al. Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza. Tanzania Trop Med Int Health. 2013;18(7):822\u20139.","journal-title":"Tanzania Trop Med Int Health"},{"issue":"6","key":"2422_CR28","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s10903-021-01231-6","volume":"23","author":"AS Chitnis","year":"2021","unstructured":"Chitnis AS, et al. Epidemiology and prevention of tuberculosis and chronic Hepatitis B virus infection in the United states. J Immigr Minor Health. 2021;23(6):1267\u201379.","journal-title":"J Immigr Minor Health"},{"issue":"5","key":"2422_CR29","first-page":"616","volume":"14","author":"JY Chien","year":"2010","unstructured":"Chien JY, et al. Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2010;14(5):616\u201321.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2422_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/1471-2458-8-245","volume":"8","author":"C Sirinak","year":"2008","unstructured":"Sirinak C, et al. Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand. BMC Public Health. 2008;8:245.","journal-title":"BMC Public Health"},{"issue":"9","key":"2422_CR31","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1017\/S0950268814002970","volume":"143","author":"G Bushnell","year":"2015","unstructured":"Bushnell G, et al. Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000\u20132010. Epidemiol Infect. 2015;143(9):1972\u201381.","journal-title":"Epidemiol Infect"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02422-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02422-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02422-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T09:24:14Z","timestamp":1741944254000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02422-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2422"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02422-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4994162\/v1","asserted-by":"object"}]},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Second Xiangya Hospital, Central South University, in accordance with the requirements of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}